Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Azitra Inc
AZTR | US
0.20
USD0.02
12.53%
AZTR | US
About Azitra Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
0.20
Open
0.18
High
0.21
Low
0.17
Azitra Inc a pre-clinical biopharmaceutical company focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12 a genetically modified strain of S. epidermidis for treating Netherton syndrome a skin disease; ATR-04 a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01 an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris a skin disease. The company was incorporated in 2014 and is based in Branford Connecticut.
View LessAZTR | US
Risk
100.9
Sharpe
-1.03
Luna's Score
48/100
Recommendation
Hold
Luna says (AZTR | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
96.8%1 month
100.9%3 months
98.6%6 months
95.9%Returns
Fundamental Ratios
PE
0.01
Fwd. PE
-
Price to book
2.42
Debt to equity
0.42
Debt to assets
0.19
Ent. to EBITDA
-0.39
Ent. to rev.
10.02
PEG
-
Other Fundamentals
EBITDA
-10.12M
MarketCap
1.55M
MarketCap(USD)
1.55M
Div. yield
-
Op. margin
-35.47K
Erngs. growth
-
Rev. growth
-95.60
Ret. on equity
-222.30
Short ratio
0.78
Short perc.
3.18
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.05
Range1M
0.07
Range3M
0.24
Volumes: Market Activity
Rel. volume
3.08
Price X volume
1.16M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.39 | 0.53 | Cheaper |
| Ent. to Revenue | 10.02 | 3,967.00 | Cheaper |
| PE Ratio | 0.01 | 41.03 | Cheaper |
| Price to Book | 2.42 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 98.60 | 72.80 | Riskier |
| Debt to Equity | 0.42 | -1.23 | Expensive |
| Debt to Assets | 0.19 | 0.25 | Cheaper |
| Market Cap | 1.55M | 3.66B | Emerging |
